Search - tctmd.com

Displaying 121 - 140 of 608

Sort: Relevancy | Date

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, John D. Carroll

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Helene Eltchaninoff

October 30, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Neil E. Moat

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Thomas Walther

October 30, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option!

Presenter: George S. Hanzel, Antoine Lafont, Daniel G Swistel

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Novel Approaches for Septal Ablation: Beyond Alcohol

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

Alcohol Septal Ablation of Ventricular Tachycardia

Presenter: Srihari S. Naidu, Paul Sorajja, George D. Dangas

October 30, 2016

Presentation TCT 2016

An Alcohol Septal Ablation Case I Regret

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

My Best Alcohol Septal Ablation Case

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2016

Advertisement

Severe AS and LV Dysfunction

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option!

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Novel Approaches for Septal Ablation: Beyond Alcohol

Alcohol Septal Ablation of Ventricular Tachycardia

An Alcohol Septal Ablation Case I Regret

My Best Alcohol Septal Ablation Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content